NO329213B1 - Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse - Google Patents

Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse Download PDF

Info

Publication number
NO329213B1
NO329213B1 NO20015666A NO20015666A NO329213B1 NO 329213 B1 NO329213 B1 NO 329213B1 NO 20015666 A NO20015666 A NO 20015666A NO 20015666 A NO20015666 A NO 20015666A NO 329213 B1 NO329213 B1 NO 329213B1
Authority
NO
Norway
Prior art keywords
immediate release
formula
acid derivative
dissolution
calcium salt
Prior art date
Application number
NO20015666A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015666D0 (no
NO20015666L (no
Inventor
Kiyohisa Ouchi
Kaoru Kaneko
Ken Kanada
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO20015666D0 publication Critical patent/NO20015666D0/no
Publication of NO20015666L publication Critical patent/NO20015666L/no
Publication of NO329213B1 publication Critical patent/NO329213B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/30—Information retrieval; Database structures therefor; File system structures therefor of unstructured textual data
    • G06F16/31—Indexing; Data structures therefor; Storage structures
    • G06F16/313—Selection or weighting of terms for indexing
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/80—Information retrieval; Database structures therefor; File system structures therefor of semi-structured data, e.g. markup language structured data such as SGML, XML or HTML
    • G06F16/83—Querying
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S707/00—Data processing: database and file management or data structures
    • Y10S707/912—Applications of a database
    • Y10S707/917—Text
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S707/00—Data processing: database and file management or data structures
    • Y10S707/953—Organization of data
    • Y10S707/955—Object-oriented
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S707/00—Data processing: database and file management or data structures
    • Y10S707/99931—Database or file accessing
    • Y10S707/99933—Query processing, i.e. searching

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Diabetes (AREA)
  • Data Mining & Analysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Databases & Information Systems (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Software Systems (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20015666A 1999-05-21 2001-11-20 Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse NO329213B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1999/002669 WO2000071117A1 (en) 1999-05-21 1999-05-21 Immediate release medicinal compositions for oral use

Publications (3)

Publication Number Publication Date
NO20015666D0 NO20015666D0 (no) 2001-11-20
NO20015666L NO20015666L (no) 2001-11-20
NO329213B1 true NO329213B1 (no) 2010-09-13

Family

ID=14235747

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015666A NO329213B1 (no) 1999-05-21 2001-11-20 Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse

Country Status (15)

Country Link
US (3) US7166301B1 (de)
EP (1) EP1179342B1 (de)
KR (1) KR100594606B1 (de)
CN (1) CN1352558B (de)
AT (1) ATE321550T1 (de)
AU (1) AU782005B2 (de)
BR (1) BR9917315A (de)
CA (1) CA2373962C (de)
DE (1) DE69930621T2 (de)
DK (1) DK1179342T3 (de)
ES (1) ES2262320T3 (de)
MX (1) MXPA01011898A (de)
NO (1) NO329213B1 (de)
PT (1) PT1179342E (de)
WO (1) WO2000071117A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0123400D0 (en) * 2001-09-28 2001-11-21 Novartis Ag Organic compounds
AU2003244083A1 (en) * 2002-06-28 2004-01-19 Kissei Pharmaceutical Co., Ltd. Drug composition for prevention or inhibition of advance of diabetic complication
KR100709528B1 (ko) * 2002-06-28 2007-04-20 깃세이 야쿠힌 고교 가부시키가이샤 혈당콘트롤용 의약조성물
US6846497B2 (en) * 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
EP1757287A4 (de) * 2004-05-11 2009-11-25 Kissei Pharmaceutical Pharmazeutische zusammensetzung zur prävention oder behandlung von lipid-stoffwechselstörungen
EP2050448A4 (de) 2006-08-08 2012-01-04 Kissei Pharmaceutical Im mund zerfallende tablette mit maskiertem bitterem geschmack und herstellungsverfahren dafür
TWI503122B (zh) 2012-02-15 2015-10-11 Taiho Pharmaceutical Co Ltd Oral administration of pharmaceutical compositions
DK2851075T3 (da) * 2012-05-14 2022-01-31 Shionogi & Co Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
CN113842362A (zh) 2012-11-14 2021-12-28 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818096A (en) * 1972-04-12 1974-06-18 Schering Corp Compositions of 1,2-dilower alkyl arylpyrazolium quaternary salts and method of lowering blood sugar levels with same
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
WO1988003023A1 (fr) * 1986-10-31 1988-05-05 Mitsubishi Chemical Industries Limited Composition de medicament contre les maladies du foie et procede de preparation
JPS63115815A (ja) * 1986-10-31 1988-05-20 Mitsubishi Kasei Corp 肝疾患治療薬組成物
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
JP2686863B2 (ja) * 1991-04-25 1997-12-08 キッセイ薬品工業株式会社 新規なベンジルコハク酸誘導体
AU654331B2 (en) * 1991-03-30 1994-11-03 Kissei Pharmaceutical Co. Ltd. Succinic acid compounds
JPH05139973A (ja) * 1991-11-20 1993-06-08 Shin Etsu Chem Co Ltd ニフエジピン含有固形製剤の製造方法
US6075024A (en) * 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
JPH0776516A (ja) * 1993-09-06 1995-03-20 Toyobo Co Ltd 難溶性薬物含有製剤の製造方法
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
US6165512A (en) * 1998-10-30 2000-12-26 Fuisz Technologies Ltd. Dosage forms containing taste masked active agents

Also Published As

Publication number Publication date
DE69930621D1 (de) 2006-05-18
CN1352558B (zh) 2012-06-13
ES2262320T3 (es) 2006-11-16
EP1179342A4 (de) 2002-09-04
AU3850599A (en) 2000-12-12
KR100594606B1 (ko) 2006-06-30
CN1352558A (zh) 2002-06-05
US7166301B1 (en) 2007-01-23
AU782005B2 (en) 2005-06-30
ATE321550T1 (de) 2006-04-15
WO2000071117A1 (en) 2000-11-30
US7160555B2 (en) 2007-01-09
MXPA01011898A (es) 2002-06-21
DE69930621T2 (de) 2006-11-09
CA2373962A1 (en) 2000-11-30
US20040192755A1 (en) 2004-09-30
NO20015666D0 (no) 2001-11-20
NO20015666L (no) 2001-11-20
KR20020015327A (ko) 2002-02-27
PT1179342E (pt) 2006-07-31
US20040197400A1 (en) 2004-10-07
DK1179342T3 (da) 2006-07-31
US7160556B2 (en) 2007-01-09
CA2373962C (en) 2009-02-24
EP1179342B1 (de) 2006-03-29
BR9917315A (pt) 2002-07-30
EP1179342A1 (de) 2002-02-13

Similar Documents

Publication Publication Date Title
JP5289338B2 (ja) 医薬固形製剤及びその製造方法
WO2005013964A1 (ja) ナテグリニド含有製剤
EP3110402A1 (de) Dapagliflozinzusammensetzungen
NO329213B1 (no) Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse
WO2005084648A1 (en) Pharmaceutical compositions comprising candesartan cilexetil
JP4063386B2 (ja) 速放性経口医薬品組成物
US6333361B1 (en) Pharmaceutical composition containing zafirlukast
EP2635263A1 (de) Zusammensetzung mit s- [2- ([[1- (2-ethylbutyl) -cyclohexyl] -carbonyl] amino)phenyl] 2-methylpropanthioat und croscarmellose-natrium
WO2022225489A1 (en) A bilayer tablet formulation comprising amorphous dapagliflozin and metformin
KR101384827B1 (ko) 소형화 염산 사포그릴레이트 경구 투여 제제
JP4072195B2 (ja) 速放性経口医薬組成物
WO2022123592A1 (en) Stable pharmaceutical composition of azilsartan medoxomil or pharmaceutical acceptable salt and processes for preparing thereof
WO2007049291A1 (en) Novel solid dosage forms of valsartan and rochlorothiazide
WO2017037645A1 (en) Stable pharmaceutical formulations of teriflunomide
WO2020122244A1 (ja) 錠剤及びその製造方法
CA2973944C (en) Solid composition of pyrrole carboxamide
JP2021193083A (ja) キサンチンオキシダーゼ阻害剤含有腸溶性製剤
EA050365B1 (ru) Лекарственная форма, содержащая аморфный твердый раствор эмпаглифлозина с полимером
JPWO2000071117A1 (ja) 速放性経口医薬品組成物
JP2011213606A (ja) ドネペジルを含有する固形製剤の製造方法
BRPI0813100B1 (pt) Preparação sólida farmacêutica e método de produção da mesma
JP2002154960A (ja) 安定な血管拡張剤及びその製造方法

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees